Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration
David Westaby, Walter Melia, John Hegarty, Alexander E. S. Gimson, Anthony J. Stellon, Roger Williams – 1 July 1986 – In a prospective, randomized controlled trial, 53 patients with variceal hemorrhage from portal hypertension, including 44 with cirrhosis, were allocated, after initial control of the bleeding, to treatment by sclerotherapy alone, or by this together with oral propranolol in a dose sufficient to reduce resting pulse rate by 25% during the period up to the time when varices were obliterated.